
CRISPR/Cas9 genome editing is an inexpensive and efficent tool to introduce changes in
DNA. Its ease of use sets virtualy no limts on potential scientfic and clincal
applications. Prospects include correctng congental monogenic dsorders, targeting
diseasecausing moecular esons,
1and even altering mutiple genetic loci at the same